Atomic Spectroscopy Market: Major Benefits And Key Features
Summary
- The Atomic Spectroscopy Market is expected to reach USD 5.60 Billion by 2020 from USD 4.18 Billion in 2015 at a CAGR of 6.0% during the forecast period.
The Atomic Spectroscopy Market is expected to reach USD 5.60 Billion by 2020 from USD 4.18 Billion in 2015 at a CAGR of 6.0% during the forecast period.
Atomic absorption segment is estimated to account for the major share of the market
Based on technology, the is market categorized into atomic absorption, X-ray Diffraction, x-ray fluorescence, ICP-MS, ICP-OES, Elemental Analyzers and other atomic spectroscopy. In 2015, atomic absorption segment is estimated to account for the major share of the atomic spectroscopy market.
Download a PDF Brochure @ Atomic Spectroscopy Market
Food & beverage testing segment is estimated to account for the major share of the market
Based on application, the atomic spectroscopy market is segmented into pharmaceuticals & biotechnology, industrial chemistry, environmental testing, food & beverage testing, petrochemical, geochemical/mining and others. In 2015, the food & beverage testing segment is estimated to account for the major share of the atomic spectroscopy market.
North America is expected to account for the largest share of the atomic spectroscopy market
On the basis of region, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2015, North America is expected to account for the largest share of the atomic spectroscopy market, followed by Europe and Asia-Pacific.
Request a Sample Pages @ Atomic Spectroscopy Market
Leading Companies
Agilent Technologies (U.S.), PerkinElmer (U.S.), Thermo Fisher Scientific (U.S.), Bruker Corporation (U.S), Rigaku Corporation (Japan), Shimadzu Corporation (Japan), Analytik Jena AG (Germany), Hitachi High-Technologies Corporation (Japan), GBC Scientific Equipment Pty Ltd (Australia), and Aurora Biomed (Canada).
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.